Historically, prostate cancer detection relied heavily on prostate-specific antigen (PSA) screening and systematic transrectal ultrasound (TRUS)-guided biopsies, which often led to the overdiagnosis of indolent cancers while missing clinically significant ones [33]. Here, KLK3 is linked to prostate cancer.